Gregorio Barila
Vicenza, 36100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.
Journal: British journal of haematology
Published: April 26, 2026
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 03, 2025
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: November 29, 2025
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations.
Journal: European journal of haematology
Published: September 27, 2025
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti- CD38 monoclonal antibodies: outcomes from a real-world experience.
Journal: Haematologica
Published: September 15, 2025
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.
Journal: Clinical and experimental medicine
Published: August 26, 2025
An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma.
Journal: Mediterranean journal of hematology and infectious diseases
Published: March 17, 2025
NK-type large granular lymphocyte leukemia comes of age.
Journal: HemaSphere
Published: March 10, 2025
Last Updated: 09/26/2026